The California Office of Environmental Health Hazard Assessment (OEHHA) issued a Notice of Intent on May 8, 2026, proposing the addition of three new chemicals to the Proposition 65 list. Hydrochlorothiazide, voriconazole, and tacrolimus—all classified under the cancer hazard category—are now under formal review. This Prop 65 notice of intent 2026 triggers immediate compliance implications for manufacturers, importers, and distributors selling products in California.

Based on currently available regulatory guidance, the specific listing mechanism—whether Labor Code, Carcinogen Identification Committee (CIC), or authoritative bodies—has not been confirmed in this notice. Regardless of the mechanism, businesses must assess product exposure risks, evaluate warning label obligations, and ensure supplier material disclosures account for these substances. The public comment period is now open, and compliance teams should begin internal reviews before the final listing decision.

📌 Book a free compliance assessment to evaluate your Proposition 65 exposure across products and supply chains.

What Is the OEHHA Proposition 65 Notice of Intent?

California's Proposition 65—formally the Safe Drinking Water and Toxic Enforcement Act—requires the state to maintain and update a list of chemicals known to cause cancer, birth defects, or reproductive harm. OEHHA administers this list and periodically proposes additions through a formal Notice of Intent process.

A Notice of Intent signals that OEHHA has identified sufficient scientific evidence to consider listing a chemical. It opens a public comment period during which stakeholders—manufacturers, trade associations, scientific bodies—can submit data, objections, or supporting evidence before the listing is finalized.

This is not a final action. However, for compliance teams managing Proposition 65 obligations across product portfolios, the Notice of Intent is the earliest actionable signal. Organizations that wait for the final listing decision lose critical preparation time.

The Prop 65 notice of intent 2026 continues California's pattern of expanding chemical coverage. With over 900 chemicals already on the list, each new addition increases the cumulative compliance burden for manufacturers selling into the California market.

Prop 65 notice of intent 2026 chemical listing process for manufacturers

Click on image to view full

Which Chemicals Are Proposed for the Prop 65 List in 2026?

OEHHA's May 8, 2026 notice proposes three chemicals, all classified as cancer hazards:

NSRL Status — Critical for Exposure Assessment

Based on currently available regulatory guidance, OEHHA has not yet published No Significant Risk Levels (NSRLs) for these three chemicals. This is the most consequential detail for compliance engineers.

⚠ Without an established NSRL, businesses cannot rely on a published safe harbor threshold. This means manufacturers must either:

• Conduct independent risk assessments to determine a de minimis exposure level

• Apply precautionary Prop 65 warnings until NSRLs are established

• Document the analytical basis for any "no warning required" determination

Compliance teams should monitor OEHHA for future NSRL publications. Until thresholds are set, the burden of demonstrating safe exposure levels falls entirely on the business.

Realistic Exposure Pathways for Non-Pharmaceutical Manufacturers

While these chemicals are primarily associated with pharmaceutical applications, Prop 65's scope extends to any product that could expose California consumers to listed substances. Compliance engineers need to understand specific, realistic exposure pathways — not just theoretical possibilities.

Water Treatment and Process Residues

Hydrochlorothiazide is one of the most widely prescribed diuretics globally and has been detected in municipal water supplies at trace concentrations. Manufacturers using water-based processes — coating, cleaning, formulation, cooling — should evaluate whether residual concentrations in finished products could trigger Prop 65 exposure thresholds.

Laboratory and Cleanroom Contamination

Voriconazole and tacrolimus are used in clinical, laboratory, and cleanroom settings. Products manufactured in facilities that also process pharmaceutical compounds — or that share equipment, packaging lines, or material handling systems — face potential cross-contamination pathways.

Recycled Material Streams

Pharmaceutical waste entering recycled plastic, paper, or water streams can introduce trace levels of these substances into consumer goods. Manufacturers sourcing post-consumer recycled (PCR) materials should assess whether incoming material streams carry detectable residues.

Medical Device and Combination Product Applications

Given that all three proposed chemicals are pharmaceutical compounds, medical device manufacturers using these substances in combination products, drug-eluting coatings, or device packaging face the most direct and immediate impact.

⚠ Prop 65 does not require the chemical to be intentionally added. Trace presence above safe harbor thresholds — or in the absence of established thresholds — triggers warning obligations.

For organizations managing chemical and hazmat compliance across diverse product lines, each new listing requires a systematic review of material compositions and process inputs, not just primary ingredients.

Industries and Product Categories Affected

Based on the nature of the proposed chemicals, exposure pathway analysis, and Prop 65's broad applicability:

📊 Electronics & Electrical Equipment — Components, plastics, coatings, and cables where water-based manufacturing processes or recycled material inputs could introduce trace residues.

📊 Consumer Goods — Household products, textiles, and packaging where chemical treatments, recycled content, or water-based formulations could trigger exposure assessments.

📊 Automotive & Industrial Manufacturing — Industrial chemicals, treated materials, and process residues. Automotive compliance teams already managing multi-framework obligations should incorporate this review into existing workflows.

📊 Medical Devices — The most directly affected sector given the pharmaceutical nature of all three proposed chemicals. Review medical device compliance management for broader context.

📊 Chemicals & Formulations — Chemical manufacturers and processors handling these compounds as raw materials, intermediates, or contaminants in waste streams.

📊 Retail & Importers — Any company selling or distributing products containing these chemicals in California bears Prop 65 warning obligations, regardless of where the product was manufactured.

How Does Prop 65 Listing Trigger Warning Requirements?

Once a chemical is officially added to the Proposition 65 list, businesses have 12 months to comply with warning requirements. The core obligation: if a product exposes a person in California to a listed chemical above the NSRL for carcinogens, a clear and reasonable warning must be provided.

Key Compliance Triggers

✓ Exposure Assessment — Determine whether the chemical is present in your products at levels that could result in consumer or occupational exposure. Without published NSRLs, businesses must generate their own exposure data.

✓ Safe Harbor Thresholds — If OEHHA subsequently establishes an NSRL, exposures below that level do not require warnings. Until then, the burden of proof rests with the business.

✓ Warning Label Obligations — Products exceeding thresholds must carry Prop 65 warnings meeting California's specific format, language, and placement requirements. Review the latest Prop 65 warning label changes for current formatting guidance.

✓ Supply Chain Documentation — Manufacturers must collect and maintain evidence of material composition from suppliers to demonstrate compliance or justify warning decisions.

For organizations using BOM substance and threshold management systems, mapping new Prop 65 chemicals to existing product structures is the critical first step. Manual reviews across thousands of SKUs are neither scalable nor audit-defensible.

Prop 65 notice of intent 2026 compliance timeline for new chemical listings

Click on image to view full

Compliance Risks, Enforcement Exposure, and Historic State Tracking

Prop 65 enforcement is primarily driven by private plaintiff attorneys and advocacy groups through "bounty hunter" lawsuits. This enforcement model creates unique risk dynamics that compliance teams must plan for proactively.

Enforcement Risk Profile

⚠ 60-Day Notice Lawsuits — Private enforcers can file lawsuits after providing a 60-day notice to the alleged violator. Settlements frequently range from tens of thousands to millions of dollars depending on product volume and distribution.

⚠ Burden of Proof on Businesses — Unlike most regulatory frameworks, Prop 65 places the burden on businesses to demonstrate that exposure levels are below safe harbor thresholds. Without robust documentation, companies cannot defend against enforcement actions.

⚠ No De Minimis Exemption Without Evidence — Businesses cannot simply claim that trace amounts are insignificant. Documented evidence — supplier declarations, test reports, exposure modeling — is required.

⚠ Retail Channel Risk — Major retailers operating in California increasingly require Prop 65 compliance documentation before accepting products. Missing or outdated declarations can result in purchase order rejections and lost shelf placement.

Why Historic State Tracking Is Non-Negotiable

Prop 65 enforcement actions frequently reference products sold months or years before the complaint. The compliance question is not "are we compliant today?" but "can we prove we were compliant on the date of sale?"

This requires historic state tracking as a data versioning problem:

✓ Immutable audit logs — Every supplier declaration, test report, and compliance decision must be recorded with timestamps that cannot be retroactively altered

✓ Time-stamped declarations — Supplier material disclosures must be date-linked to specific product versions and shipment periods

✓ Point-in-time queries — Compliance systems must support retrieval of the exact compliance state of any product at any historical date

✓ Evidence chain integrity — For every compliance data point, the system must record who provided the evidence, when it was provided, and with what authority

No compliance system eliminates audit findings entirely. The objective is to reduce surprises and compress response time from weeks to hours. Organizations maintaining a centralized compliance data backbone can retrieve complete evidence chains within minutes when a 60-day notice arrives.

Audit Type Distinctions

Different audit scenarios require different evidence packages:

📌 Regulatory inspection (CPSC, California AG enforcement) — Requires exposure modeling data, analytical test reports, and documented safe harbor calculations

📌 Customer audit (OEM-driven) — Requires supplier declarations, certificates of analysis, and BOM-level substance mapping. Companies like Apple and Microsoft maintain customer trust center models that demand structured compliance evidence from their supply base

📌 Internal audit — Requires documented decision rationale — why a specific product does or does not require a Prop 65 warning

📌 Certification audit (ISO 14001) — Requires evidence of regulatory tracking processes, not just substance-level data

Maintaining continuous audit-ready documentation across all four audit types is the only sustainable approach at enterprise scale.

What Should Manufacturers Do Now?

Compliance teams should begin the following actions immediately, without waiting for the final listing decision:

✅ 1. Screen Products for Proposed Chemicals — Review material compositions across product lines for hydrochlorothiazide, voriconazole, and tacrolimus. Prioritize medical devices, pharmaceutical-adjacent products, water-based formulations, and products using recycled material inputs.

✅ 2. Issue Targeted Supplier Disclosure Requests — Do not send generic questionnaires. Specifically request:

• Full material disclosure (FMD) or certificates of analysis (CoA) covering all three proposed chemicals

• Confirmation of whether these chemicals are intentionally added, present as impurities, or below analytical detection limits

• The analytical method and detection limits used in testing

• Timestamp all supplier response records for evidence chain integrity

Use standardized supplier questionnaire frameworks to ensure consistent, auditable data collection across the supplier base.

✅ 3. Assess Exposure Levels — For products where the chemicals are identified, conduct or commission exposure assessments. Without published NSRLs, businesses must generate their own safe harbor calculations or apply precautionary warnings.

✅ 4. Evaluate Labeling and Warning Obligations — If exposure exceeds determined thresholds, prepare warning labels and consumer-facing communications that comply with Prop 65's current format requirements.

✅ 5. Submit Public Comments to OEHHA — If your organization has relevant scientific data, exposure modeling, or regulatory perspective, submit comments during the public comment period. Industry input influences final listing decisions and threshold-setting. Based on currently available regulatory guidance, the specific comment deadline should be confirmed directly with OEHHA.

✅ 6. Activate Regulatory Horizon Scanning — Ensure your compliance team is tracking the regulatory timeline for final listing confirmation and NSRL establishment. Regulatory intelligence and horizon scanning capabilities ensure alerts arrive before deadlines, not after.

✅ 7. Update Customer-Facing Compliance Documentation — For B2B manufacturers, ensure that customer trust centers, declarations, test reports, and compliance statements reflect the status of proposed chemicals. Customer audit readiness depends on proactive updates.

📌 Managing Prop 65 across a large product portfolio? See how Certivo automates substance tracking and supplier disclosure collection → Book a Demo

Cross-Framework Regulatory Implications

Compliance engineers at global manufacturers do not manage Prop 65 in isolation. These three chemicals should be cross-referenced against obligations under parallel regulatory frameworks:

✓ REACH SVHC Candidate List — Verify whether hydrochlorothiazide, voriconazole, or tacrolimus appear on ECHA's current or anticipated SVHC candidate lists. Overlapping REACH and Prop 65 obligations create compounding documentation requirements.

✓ TSCA Inventory Status — Confirm the regulatory status of these chemicals under EPA's Toxic Substances Control Act, particularly for manufacturers importing or processing these substances in the United States.

✓ EU CLP Classification — Review whether these chemicals carry harmonized CLP classifications that may trigger additional labeling or restriction obligations in EU markets.

✓ PFAS and Broader Chemical Compliance — While these specific chemicals are not PFAS compounds, the compliance workflows required — supplier disclosure, substance mapping, threshold monitoring — are identical. Organizations already building infrastructure for PFAS compliance can leverage the same systems.

A single substance addition can trigger compliance actions under multiple frameworks simultaneously. Platforms that support materials and environmental compliance across jurisdictions prevent duplicated effort and ensure consistent substance tracking regardless of which regulation initiated the review.

Prop 65 notice of intent 2026 compliance preparation checklist for manufacturers

Click on image to view full

How AI Reduces Prop 65 Compliance Burden

Each new Proposition 65 listing multiplies the manual effort required to assess, document, and report compliance across product portfolios and supply chains. For organizations managing thousands of SKUs and hundreds of suppliers, the operational challenge is not understanding the regulation — it is executing the response at scale.

Automated Supplier Data Collection

Certivo's supplier self-service compliance portals enable targeted disclosure requests for specific chemicals. When OEHHA proposes new listings, compliance teams can launch focused campaigns across their supplier base — collecting FMDs, CoAs, and detection limit data — without manual email chains or spreadsheet tracking.

AI Document Parsing and Certificate Validation

CORA-powered regulatory intelligence extracts substance data from supplier declarations, test reports, and certificates of analysis. CORA identifies whether proposed chemicals appear in supplier-provided documentation, flags incomplete disclosures, validates data consistency across submissions, and maintains the evidence chain — recording who provided each document, when, and with what authority.

BOM-Level Material Mapping

Connecting substance data to specific products and BOMs is where most manual programs break down. Certivo maps supplier declarations to BOM-level compliance intelligence, enabling compliance teams to answer the critical question: "Which of our finished products contain this chemical?" — without manual cross-referencing across thousands of parts.

Regulatory Intelligence and Horizon Scanning

CORA's regulatory intelligence layer tracks Prop 65 Notices of Intent, final listings, NSRL publications, and enforcement trends. This shifts compliance teams from reactive responses to proactive risk management — identifying exposure before it becomes an enforcement action.

Historic State Retrieval

When a 60-day notice references a product sold 18 months ago, CORA supports point-in-time compliance queries — retrieving the exact supplier declarations, test data, and compliance determinations that were in effect on the date of sale. This capability transforms audit response from a multi-week document hunt into a same-day evidence package.

For a broader perspective on AI in compliance, see the Complete Guide to AI Tools for Compliance Management.

Conclusion

OEHHA's May 2026 Prop 65 notice of intent to list hydrochlorothiazide, voriconazole, and tacrolimus reinforces California's trajectory of expanding chemical coverage under Proposition 65. While these are pharmaceutical compounds, the regulation's broad scope means any manufacturer whose products could contain these substances — through intentional use, process contamination, recycled material streams, or water-based manufacturing inputs — must evaluate exposure risk and warning obligations.

The absence of published NSRLs for these chemicals places the full burden of exposure assessment on businesses. The public comment period is open now. Compliance teams should not wait for the final listing decision to begin product screening, supplier engagement, and exposure modeling.

Cross-framework implications — REACH, TSCA, EU CLP — mean that this Prop 65 action should be addressed within integrated compliance workflows, not as an isolated California task. Organizations that treat Notices of Intent as early-warning signals maintain audit readiness and avoid the reactive scramble that follows final listings.

Investing in AI-native compliance automation, centralized supplier data collection, and regulatory intelligence and horizon scanning ensures that each new Prop 65 addition is absorbed into existing compliance workflows — with full evidence chain integrity, historic state tracking, and audit-ready documentation — without proportional increases in manual effort.

📌 Book a demo to see how Certivo automates Proposition 65 compliance across your product portfolio and multi-tier supply chain — from supplier disclosure collection to BOM-level substance tracking and audit-ready documentation for every new chemical listing.

FAQs

1. When will the three proposed chemicals be officially added to the Prop 65 list?

Based on currently available regulatory guidance, the final listing decision depends on the outcome of the public comment period initiated on May 8, 2026. If OEHHA proceeds, businesses typically have 12 months from the listing date to comply with warning requirements. Certivo's CORA intelligence monitors OEHHA timelines and alerts compliance teams before deadlines take effect.

2. Are hydrochlorothiazide, voriconazole, and tacrolimus relevant to non-pharmaceutical manufacturers?

Yes. Prop 65 applies to any product that could expose California consumers to a listed chemical. Hydrochlorothiazide, for example, has been detected in municipal water supplies — meaning manufacturers using water-based processes such as coating, cleaning, or formulation should evaluate whether residual concentrations in finished products could trigger exposure thresholds. Automated supplier data collection through Certivo helps identify these pathways across complex BOMs.

3. What evidence is needed to defend against a Prop 65 enforcement action?

The specific evidence depends on the audit type. Regulatory enforcement requires exposure modeling and analytical test reports. Customer audits require supplier declarations and BOM-level substance mapping. In all cases, maintaining time-stamped, immutable records — including who provided each data point and when — is essential. No compliance system eliminates findings, but the goal is compressing response time from weeks to hours.

4. How should compliance teams handle the absence of published NSRLs for these chemicals?

Without established NSRLs, businesses must conduct independent risk assessments to determine de minimis exposure levels or apply precautionary Prop 65 warnings. Document all analytical methods, detection limits, and exposure calculations to maintain audit-defensible records. CORA-driven compliance intelligence can flag products for review and track NSRL publications as OEHHA releases them.

5. Should these chemicals be cross-referenced against REACH, TSCA, or other frameworks?

Yes. Global manufacturers should verify whether these chemicals appear on REACH SVHC candidate lists, TSCA inventories, or EU CLP harmonized classifications. Overlapping obligations across jurisdictions mean a single Prop 65 listing can trigger parallel compliance actions. Certivo's multi-framework compliance infrastructure enables simultaneous tracking across regulatory regimes without duplicated manual effort.